Cargando…
Navigating use of rituximab during the COVID-19 pandemic
Autores principales: | Elahee, Mehreen, Sattui, Sebastian E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831611/ https://www.ncbi.nlm.nih.gov/pubmed/36644691 http://dx.doi.org/10.1016/S2665-9913(23)00005-X |
Ejemplares similares
-
Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021) -
Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
por: Boekel, L, et al.
Publicado: (2022) -
Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022) -
What does endemic COVID-19 mean for the future of rituximab?
por: Liew, David F L, et al.
Publicado: (2022) -
COVID-19 and involuntary hospitalisation: navigating the challenge
por: Gold, Azgad, et al.
Publicado: (2020)